This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Biotech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Elena Lasorsa: Innovator in CAR-T Cell Technology
Introduction
Elena Lasorsa is a prominent inventor based in Antwerp, Belgium. She has made significant contributions to the field of immunotherapy, particularly in the development of CAR-T cell technology. Her innovative work has the potential to transform cancer treatment and improve patient outcomes.
Latest Patents
Elena holds a patent for "ANTI-CD79 CHIMERIC ANTIGEN RECEPTORS, CAR-T CELLS, AND USES THEREOF." This patent represents a crucial advancement in the design and application of CAR-T cells, which are engineered to target specific cancer cells.
Career Highlights
Elena is currently employed at Janssen Biotech, Inc., where she continues to push the boundaries of cancer research. Her work at this leading biotechnology company has positioned her as a key player in the development of innovative therapies.
Collaborations
Elena collaborates with esteemed colleagues, including Ulrike Philippar and Rajkumar Ganesan. These partnerships enhance her research and contribute to the advancement of CAR-T cell technology.
Conclusion
Elena Lasorsa's contributions to the field of immunotherapy through her patent and work at Janssen Biotech, Inc. highlight her role as an influential inventor. Her ongoing research promises to make a lasting impact on cancer treatment.